Extra-domain B of fibronectin as an alternative target for drug delivery and a cancer diagnostic and prognostic biomarker for malignant glioma
Conclusions: Taken together, these results show that EDB-FN can be an effective drug delivery target and biomarker for MG.
Source: Theranostics - Category: Molecular Biology Authors: Phei Er Saw, Xiaoding Xu, Bo Ram Kang, Jungsul Lee, Yeo Song Lee, Chungyeul Kim, Hyungsin Kim, Shin-Hyuk Kang, Yoo Jin Na, Hong Joo Moon, Joo Han Kim, Youn-Kwan Park, Wonki Yoon, Jong Hyun Kim, Taek-Hyun Kwon, Chulhee Choi, Sangyong Jon, Kyuha Chong Tags: Research Paper Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Databases & Libraries | Docetaxel | Glioma | Head and Neck Cancer | Molecular Biology | Nanotechnology | Neurology | Study | Taxotere